ArticleAntibiotics (Basel, Switzerland)2021

Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives.

Davide Fiore Bavaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.